Pradžia › Geografinė atrofija › Washington
Geografinė atrofija klinikiniai tyrimai Washington
6 tyrimai dėl Geografinė atrofija ieško dalyvių vietose Washington.
Miestai Washington
Oficialus tyrimo tekstas (anglų kalba)
A Long-term Extension Study of JNJ-81201887 (AAVCAGsCD59) Parent Studies in Participants With Geographic Atrophy (GA) Secondary to Age-related Macular Degeneration (AMD)
- Spokane Eye Clinical Research, Spokane
Renkami dalyviai2/3 fazė
Amžius 60 ir vyresni · Visoms lytims · Atnaujinta 2026-09-30 · NCT06635148A Phase 1/2 Study of the Safety and Efficacy of BRX011 Oral Administration Once Daily in Subjects With Geographic Atrophy Secondary to Age-Related Macular Degeneration
- Spokane Eye Clinic, Spokane
Renkami dalyviai1/2 fazė
Amžius 55 ir vyresni · Visoms lytims · Atnaujinta 2026-09-23 · NCT07029945A Study Investigating Subcutaneously Administered Pozelimab in Combination With Cemdisiran or Cemdisiran Alone in Adult Participants With Geographic Atrophy
- Spokane Eye Clinical Research, Spokane
Renkami dalyviai3 fazė
Amžius nuo 50 iki 85 · Visoms lytims · Atnaujinta 2026-09-18 · NCT06541704A Study to Optimize Subretinal Surgical Delivery and to Evaluate Safety and Activity of Opregen in Participants With Geographic Atrophy Secondary to Age-Related Macular Degeneration (GAlette); Adaptive Optics (AO) Retinal Imaging Substudy in Association With Study GR44251
- Spokane Eye Clinical Research;Spokane Eye Surgery Center, Spokane
Renkami dalyviai2 fazė
Amžius 50 ir vyresni · Visoms lytims · Atnaujinta 2026-09-15 · NCT05626114Study to Evaluate Efficacy and Safety of ONL1204 in Patients With GA Associated With AMD
- Pacific Northwest Retina, Bellevue
- Pacific Northwest Retina, PLLC, Silverdale
Renkami dalyviai2 fazė
Amžius 55 ir vyresni · Visoms lytims · Atnaujinta 2026-09-10 · NCT06659445A Study of the Safety and Tolerability of ASP7317 in Senior Adults Who Are Losing Their Clear, Sharp Central Vision Due to Geographic Atrophy Secondary to Dry Age-related Macular Degeneration
- Spokane Eye Clinical Research, Spokane
Renkami dalyviai1 fazė
Amžius 50 ir vyresni · Visoms lytims · Atnaujinta 2026-09-03 · NCT03178149Iš ClinicalTrials.gov, duomenys gauti 2026-10-05. Kiekvienas tyrimas nustato savo tinkamumo kriterijus; tyrimo komanda sprendžia, kas gali dalyvauti.